CA986012A - Pharmaceutical compositions containing a local anaesthetic and saxitoxin - Google Patents

Pharmaceutical compositions containing a local anaesthetic and saxitoxin

Info

Publication number
CA986012A
CA986012A CA130,378A CA130378A CA986012A CA 986012 A CA986012 A CA 986012A CA 130378 A CA130378 A CA 130378A CA 986012 A CA986012 A CA 986012A
Authority
CA
Canada
Prior art keywords
saxitoxin
pharmaceutical compositions
compositions containing
local anaesthetic
anaesthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA130,378A
Other languages
English (en)
Other versions
CA130378S (en
Inventor
Herbert J.F. Adams
Bertil H. Takman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra USA Inc
Original Assignee
Astra Pharmaceutical Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharmaceutical Products Inc filed Critical Astra Pharmaceutical Products Inc
Application granted granted Critical
Publication of CA986012A publication Critical patent/CA986012A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA130,378A 1971-01-26 1971-12-17 Pharmaceutical compositions containing a local anaesthetic and saxitoxin Expired CA986012A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10994271A 1971-01-26 1971-01-26

Publications (1)

Publication Number Publication Date
CA986012A true CA986012A (en) 1976-03-23

Family

ID=22330411

Family Applications (2)

Application Number Title Priority Date Filing Date
CA130,378A Expired CA986012A (en) 1971-01-26 1971-12-17 Pharmaceutical compositions containing a local anaesthetic and saxitoxin
CA130,377A Expired CA983850A (en) 1971-01-26 1971-12-17 Pharmaceutical compositions containing a local anaesthetic, tetrodotoxin and desoxytetrodotoxin

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA130,377A Expired CA983850A (en) 1971-01-26 1971-12-17 Pharmaceutical compositions containing a local anaesthetic, tetrodotoxin and desoxytetrodotoxin

Country Status (18)

Country Link
AT (2) AT310939B (es)
AU (1) AU465875B2 (es)
BE (2) BE776768A (es)
BR (2) BR7108428D0 (es)
CA (2) CA986012A (es)
DD (2) DD96400A5 (es)
DE (2) DE2163055A1 (es)
DK (2) DK130389B (es)
ES (2) ES398109A1 (es)
FR (2) FR2123278B1 (es)
GB (1) GB1370904A (es)
HU (2) HU162185B (es)
IE (2) IE35937B1 (es)
LU (1) LU64664A1 (es)
NL (2) NL7117404A (es)
NO (2) NO135892C (es)
SE (2) SE391286B (es)
ZA (2) ZA718327B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030974A (en) * 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition
AU7389098A (en) 1997-05-16 1998-12-08 Brigham And Women's Hospital Local anesthetic formulations
US9018222B2 (en) 2006-03-27 2015-04-28 Wex Medical Limited Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
NZ710890A (en) 2013-03-15 2016-11-25 Childrens Medical Ct Corp Neosaxitoxin combination formulations for prolonged local anesthesia

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030974A (en) * 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia

Also Published As

Publication number Publication date
BE776768A (fr) 1972-06-16
NO135892C (no) 1978-05-16
BR7108428D0 (pt) 1973-06-14
NL7117401A (es) 1972-07-28
NO135891B (es) 1977-03-14
NO135891C (no) 1978-05-16
ES398108A1 (es) 1975-03-01
FR2123277B1 (es) 1975-06-13
IE35937B1 (en) 1976-07-07
ZA718327B (en) 1972-09-27
FR2123278B1 (es) 1975-08-01
NL7117404A (es) 1972-07-28
ZA718326B (en) 1972-09-27
DE2163055A1 (de) 1972-10-12
IE35937L (en) 1972-07-26
DD96400A5 (es) 1973-03-20
HU162347B (es) 1973-02-28
FR2123278A1 (es) 1972-09-08
AT310939B (de) 1973-10-25
IE35910L (en) 1972-07-26
IE35910B1 (en) 1976-06-23
BR7108429D0 (pt) 1973-06-14
NO135892B (es) 1977-03-14
AT310938B (de) 1973-10-25
AU3710171A (en) 1973-06-28
SE391127B (sv) 1977-02-07
LU64664A1 (es) 1972-08-23
AU3710071A (en) 1973-06-28
DK130389B (da) 1975-02-17
DK131606B (da) 1975-08-11
DE2163054B2 (de) 1978-06-01
ES398109A1 (es) 1975-03-16
DE2163054C3 (de) 1979-02-01
DK130389C (es) 1975-07-14
FR2123277A1 (es) 1972-09-08
GB1370904A (en) 1974-10-16
DK131606C (da) 1976-01-12
DD96144A5 (es) 1973-03-12
HU162185B (es) 1973-01-29
SE391286B (sv) 1977-02-14
AU465875B2 (en) 1975-10-09
DE2163054A1 (de) 1974-05-02
BE776769A (fr) 1972-06-16
CA983850A (en) 1976-02-17

Similar Documents

Publication Publication Date Title
AU482733B2 (en) Pharmaceutical compositions
CA981582A (en) Coronary dilator in a pharmaceutical dosage unit form
CA970685A (en) Composition containing inhalation medicaments
CA1009144A (en) Medicinal capsules
CA979859A (en) Medication container
CA986012A (en) Pharmaceutical compositions containing a local anaesthetic and saxitoxin
CA974170A (en) Pharmaceutical compositions
PH10227A (en) 1-substituted benzodiazepine-2-ones and pharmaceutical compositions containing the same
PH11404A (en) 2(n-substituted-phenylamino)-imidazolines-(2)and pharmaceutical compositions thereof
AU476623B2 (en) 3 7-hydroxy-19-nor-5d-pregnane-11, 20-dione and pharmaceutical compositions thereof
IL41035A (en) N-lysergyl-3'-amino-pyridine derivatives,their production and pharmaceutical compositions containing them
CA953107A (en) Panneau d'affichage
IL40828A0 (en) Dibenzothiepin derivatives,their manufacture and pharmaceutical compositions containing them
GB1400842A (en) Oxaprostanoic acid derivatives and pharmaceutical compositions containing the same
AU461136B2 (en) Pharmaceutical composition
IL38772A (en) Aminopropenyl-anthracene derivatives,their manufacture and pharmaceutical compositions containing them
CA883791A (en) Spasmolytic pharmaceutical compositions
CA887648A (en) N-arallyl-n'-aralkyl piperazines and pharmaceutical compositions thereof
CA972103A (en) Concrete-curing and antispalling compositions
CA885421A (en) Pharmaceutical composition
CA884857A (en) Pharmaceutical composition
AU2587871A (en) Medicament
CA873314A (en) Anaesthetic compositions
AU466053B2 (en) Local anesthetic compositions
CA884860A (en) Pharmaceutical compositions